# NextPlat Corp: financial statements, quarterly

NXPL · Nasdaq · CIK 1058307 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxpl.md) · [Financials](/companies/nxpl/financials.md) · [Filings](/companies/nxpl/filings.md) · [Insiders](/companies/nxpl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nxpl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.3](/filings/0001437749-24-034987.md) | [16.6 d](/filings/0001437749-25-008787.md) | [17.5](/filings/0001437749-25-016943.md) | [17.0](/filings/0001437749-25-026604.md) | [15.4](/filings/0001437749-25-034525.md) | [16.2 d](/filings/0001437749-26-010668.md) | [13.9](/filings/0001437749-26-017156.md) | [13.2](/filings/0001437749-26-027772.md) | [13.8](/filings/0001437749-25-034525.md) | [12.8 d](/filings/0001437749-26-010668.md) | [9.9](/filings/0001437749-26-017156.md) | [11.9](/filings/0001437749-26-027772.md) |
| Cost of revenue | $m | [10.7](/filings/0001437749-24-034987.md) | [11.4 d](/filings/0001437749-25-008787.md) | [12.6](/filings/0001437749-25-016943.md) | [11.1](/filings/0001437749-25-026604.md) | [11.8](/filings/0001437749-25-034525.md) | [13.5 d](/filings/0001437749-26-010668.md) | [11.1](/filings/0001437749-26-017156.md) | [10.4](/filings/0001437749-26-027772.md) | [11.0](/filings/0001437749-25-034525.md) | [11.0 d](/filings/0001437749-26-010668.md) | [6.4](/filings/0001437749-26-017156.md) | [7.2](/filings/0001437749-26-027772.md) |
| Gross profit | $m | [4.6](/filings/0001437749-24-034987.md) | [5.3 d](/filings/0001437749-25-008787.md) | [4.9](/filings/0001437749-25-016943.md) | [5.9](/filings/0001437749-25-026604.md) | [3.6](/filings/0001437749-25-034525.md) | [2.7 d](/filings/0001437749-26-010668.md) | [2.9](/filings/0001437749-26-017156.md) | [2.9](/filings/0001437749-26-027772.md) | [2.7](/filings/0001437749-25-034525.md) | [1.8 d](/filings/0001437749-26-010668.md) | [3.4](/filings/0001437749-26-017156.md) | [4.7](/filings/0001437749-26-027772.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [4.2](/filings/0001437749-24-034987.md) | [2.4 d](/filings/0001437749-25-008787.md) | [1.4](/filings/0001437749-25-016943.md) | [1.6](/filings/0001437749-25-026604.md) | [1.7](/filings/0001437749-25-034525.md) | [1.5 d](/filings/0001437749-26-010668.md) | [2.0](/filings/0001437749-26-017156.md) | [2.0](/filings/0001437749-26-027772.md) | [1.5](/filings/0001437749-25-034525.md) | [1.6 d](/filings/0001437749-26-010668.md) | [2.0](/filings/0001437749-26-017156.md) | [2.4](/filings/0001437749-26-027772.md) |
| Operating income | $m | [(3.5)](/filings/0001437749-24-034987.md) | [(15.2) d](/filings/0001437749-25-008787.md) | [(1.8)](/filings/0001437749-25-016943.md) | [(10.9)](/filings/0001437749-25-026604.md) | [(8.0)](/filings/0001437749-25-034525.md) | [(2.3) d](/filings/0001437749-26-010668.md) | [(2.1)](/filings/0001437749-26-017156.md) | [(1.8)](/filings/0001437749-26-027772.md) | [(2.0)](/filings/0001437749-25-034525.md) | [(3.7) d](/filings/0001437749-26-010668.md) | [(1.1)](/filings/0001437749-26-017156.md) | [(0.1)](/filings/0001437749-26-027772.md) |
| Interest expense | $m | [0.0](/filings/0001437749-23-031707.md) | [0.0 d](/filings/0001437749-24-011806.md) | [0.0](/filings/0001437749-24-017030.md) | [0.0](/filings/0001437749-25-026604.md) | [0.0](/filings/0001437749-25-034525.md) | [0.0 d](/filings/0001437749-26-010668.md) | [0.0](/filings/0001437749-25-016943.md) | [0.0](/filings/0001437749-25-026604.md) | [0.0](/filings/0001437749-25-034525.md) | [0.0 d](/filings/0001437749-26-010668.md) | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-034987.md) | [(0.0) d](/filings/0001437749-25-008787.md) | [0.0](/filings/0001437749-25-016943.md) | [0.0](/filings/0001437749-25-026604.md) | [0.0](/filings/0001437749-25-034525.md) | [(0.0) d](/filings/0001437749-26-010668.md) | [0.0](/filings/0001437749-26-017156.md) | [0.0](/filings/0001437749-26-027772.md) | [(0.0)](/filings/0001437749-25-034525.md) | [(0.0) d](/filings/0001437749-26-010668.md) | [0.0](/filings/0001437749-26-017156.md) | [0.0](/filings/0001437749-26-027772.md) |
| Net income | $m | [3.4](/filings/0001437749-24-034987.md) | [(1.7) d](/filings/0001437749-25-008787.md) | [(1.5)](/filings/0001437749-25-016943.md) | [(5.3)](/filings/0001437749-25-026604.md) | [(4.2)](/filings/0001437749-25-034525.md) | [(3.0) d](/filings/0001437749-25-008787.md) | [(1.9)](/filings/0001437749-26-017156.md) | [(1.8)](/filings/0001437749-26-027772.md) | [(2.2)](/filings/0001437749-25-034525.md) | [(5.1) d](/filings/0001437749-26-010668.md) | [(1.1)](/filings/0001437749-26-017156.md) | [(0.1)](/filings/0001437749-26-027772.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001437749-24-034987.md) | not reported | [(0.08)](/filings/0001437749-25-016943.md) | not reported | [(0.22)](/filings/0001437749-24-034987.md) | not reported | [(0.05)](/filings/0001437749-25-016943.md) | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.18](/filings/0001437749-24-034987.md) | not reported | [(0.08)](/filings/0001437749-25-016943.md) | [(0.28)](/filings/0001437749-25-026604.md) | [(0.22)](/filings/0001437749-25-034525.md) | not reported | [(0.75)](/filings/0001437749-26-017156.md) | [(0.69)](/filings/0001437749-26-027772.md) | [(0.08)](/filings/0001437749-25-034525.md) | not reported | [(0.42)](/filings/0001437749-26-017156.md) | [(0.05)](/filings/0001437749-26-027772.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.3](/filings/0001437749-23-031707.md) | [26.3](/filings/0001437749-25-008787.md) | [23.5](/filings/0001437749-24-017030.md) | [24.9](/filings/0001437749-24-026477.md) | [20.4](/filings/0001437749-24-034987.md) | [20.0](/filings/0001437749-26-010668.md) | [17.7](/filings/0001437749-25-016943.md) | [16.6](/filings/0001437749-25-026604.md) | [13.9](/filings/0001437749-25-034525.md) | [13.7](/filings/0001437749-26-027772.md) | [11.0](/filings/0001437749-26-017156.md) | [11.9](/filings/0001437749-26-027772.md) |
| Current assets | $m | [43.7](/filings/0001437749-23-031707.md) | [43.6](/filings/0001437749-25-008787.md) | [45.3](/filings/0001437749-24-017030.md) | [42.0](/filings/0001437749-24-026477.md) | [35.8](/filings/0001437749-24-034987.md) | [32.1](/filings/0001437749-26-010668.md) | [30.5](/filings/0001437749-25-016943.md) | [26.9](/filings/0001437749-25-026604.md) | [26.2](/filings/0001437749-25-034525.md) | [24.2](/filings/0001437749-26-027772.md) | [23.3](/filings/0001437749-26-017156.md) | [25.1](/filings/0001437749-26-027772.md) |
| Total assets | $m | [66.2](/filings/0001437749-23-031707.md) | [64.5](/filings/0001437749-25-008787.md) | [65.1](/filings/0001437749-24-017030.md) | [51.5](/filings/0001437749-24-026477.md) | [41.1](/filings/0001437749-24-034987.md) | [37.1](/filings/0001437749-26-010668.md) | [35.2](/filings/0001437749-25-016943.md) | [31.0](/filings/0001437749-25-026604.md) | [30.0](/filings/0001437749-25-034525.md) | [27.5](/filings/0001437749-26-027772.md) | [26.9](/filings/0001437749-26-017156.md) | [28.7](/filings/0001437749-26-027772.md) |
| Current liabilities | $m | [14.7](/filings/0001437749-23-031707.md) | [14.2](/filings/0001437749-25-008787.md) | [16.0](/filings/0001437749-24-017030.md) | [12.8](/filings/0001437749-24-026477.md) | [9.7](/filings/0001437749-24-034987.md) | [8.2](/filings/0001437749-26-010668.md) | [8.4](/filings/0001437749-25-016943.md) | [6.2](/filings/0001437749-25-026604.md) | [7.4](/filings/0001437749-25-034525.md) | [9.1](/filings/0001437749-26-027772.md) | [9.1](/filings/0001437749-26-017156.md) | [11.0](/filings/0001437749-26-027772.md) |
| Total liabilities | $m | [16.7](/filings/0001437749-23-031707.md) | [16.4](/filings/0001437749-25-008787.md) | [18.0](/filings/0001437749-24-017030.md) | [14.5](/filings/0001437749-24-026477.md) | [11.3](/filings/0001437749-24-034987.md) | [9.7](/filings/0001437749-26-010668.md) | [9.8](/filings/0001437749-25-016943.md) | [7.4](/filings/0001437749-25-026604.md) | [8.5](/filings/0001437749-25-034525.md) | [10.0](/filings/0001437749-26-027772.md) | [10.3](/filings/0001437749-26-017156.md) | [12.2](/filings/0001437749-26-027772.md) |
| Long-term debt | $m | [1.6](/filings/0001437749-23-031707.md) | [1.5](/filings/0001437749-24-011806.md) | [1.4](/filings/0001437749-24-017030.md) | [1.3](/filings/0001437749-24-026477.md) | [1.5](/filings/0001437749-24-034987.md) | [1.4](/filings/0001437749-25-008787.md) | [1.3](/filings/0001437749-25-016943.md) | [1.2](/filings/0001437749-25-026604.md) | [1.2](/filings/0001437749-25-034525.md) | [1.3](/filings/0001437749-26-010668.md) | [1.2](/filings/0001437749-26-017156.md) | [1.0](/filings/0001437749-26-027772.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [33.2](/filings/0001437749-23-031707.md) | [32.2](/filings/0001437749-25-008787.md) | [31.2](/filings/0001437749-24-017030.md) | [26.5](/filings/0001437749-24-026477.md) | [22.5](/filings/0001437749-24-034987.md) | [27.3](/filings/0001437749-26-010668.md) | [25.3](/filings/0001437749-25-016943.md) | [23.5](/filings/0001437749-25-026604.md) | [21.4](/filings/0001437749-25-034525.md) | [17.3](/filings/0001437749-26-027772.md) | [16.5](/filings/0001437749-26-017156.md) | [16.4](/filings/0001437749-26-027772.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(947) d](/filings/0001437749-24-034987.md) | [651 d](/filings/0001437749-25-008787.md) | [(2,685)](/filings/0001437749-25-016943.md) | [2,306 d](/filings/0001437749-25-026604.md) | [(4,609) d](/filings/0001437749-25-034525.md) | [(476) d](/filings/0001437749-26-010668.md) | [(2,059)](/filings/0001437749-26-017156.md) | [(1,041) d](/filings/0001437749-26-027772.md) | [(2,728) d](/filings/0001437749-25-034525.md) | [(302) d](/filings/0001437749-26-010668.md) | [(2,583)](/filings/0001437749-26-017156.md) | [1,085 d](/filings/0001437749-26-027772.md) |
| Capital expenditure | $k | [355 d](/filings/0001437749-24-034987.md) | [189 d](/filings/0001437749-25-008787.md) | [64.0](/filings/0001437749-25-016943.md) | [60.0 d](/filings/0001437749-25-026604.md) | [97.0 d](/filings/0001437749-25-034525.md) | [(32.0) d](/filings/0001437749-26-010668.md) | [22.0](/filings/0001437749-26-017156.md) | [12.0 d](/filings/0001437749-26-027772.md) | [0.0 d](/filings/0001437749-25-034525.md) | [37.0 d](/filings/0001437749-26-010668.md) | [0.0](/filings/0001437749-26-017156.md) | [0.0 d](/filings/0001437749-26-027772.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-010668.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-010668.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.5](/filings/0001437749-23-031707.md) | [14.4](/filings/0001437749-24-017030.md) | [18.1](/filings/0001437749-24-026477.md) | [20.3](/filings/0001437749-24-034987.md) | [18.7](/filings/0001437749-25-016943.md) | [18.8](/filings/0001437749-25-026604.md) | [19.0](/filings/0001437749-25-034525.md) | [2.6](/filings/0001437749-26-017156.md) | [2.6](/filings/0001437749-26-027772.md) | [26.0](/filings/0001437749-25-034525.md) | [2.7](/filings/0001437749-26-017156.md) | [2.7](/filings/0001437749-26-027772.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,713,222 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-027772.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.